Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia.
about
A Role for Estrogen in Schizophrenia: Clinical and Preclinical FindingsUtilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neuronsSelective Estrogen Receptor Modulation Increases Hippocampal Activity during Probabilistic Association Learning in SchizophreniaHormone modulation improves cognition in schizophrenia.Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial.Potential Role of Oestrogen Modulation in the Treatment of Neurocognitive Deficits in SchizophreniaAdjunctive selective estrogen receptor modulator increases neural activity in the hippocampus and inferior frontal gyrus during emotional face recognition in schizophrenia.Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia?Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a meta-analysis of randomized controlled trials.Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries.Drugs, games, and devices for enhancing cognition: implications for work and society.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders.Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia.Improving Current Treatments for Schizophrenia.Sex-dependent alterations in resting-state cerebral blood flow, amplitude of low-frequency fluctuations and their coupling relationship in schizophrenia.Estrogen Signaling as a Therapeutic Target in Neurodevelopmental Disorders.Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder.Raloxifene Improves Cognition in Schizophrenia: Spurious Result or Valid Effect?The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis.Selective enhancement of NMDA receptor-mediated locomotor hyperactivity by male sex hormones in mice.Understanding role of steroids in typical and atypical brain development: Advantages of using a "brain in a dish" approach.The effect of estrogenic compounds on psychosis-like behaviour in female rats.The Importance of Social Cognition in Improving Functional Outcomes in Schizophrenia.C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy ControlsTranslational Significance of Selective Estrogen Receptor Modulators in Psychiatric Disorders
P2860
Q26778420-5549BB72-E01F-4673-BC91-04BD5CB7C6DFQ28081565-8213D8EF-6AC4-4E9A-8219-72179D757785Q35960350-E9707078-1242-49CC-A401-B0946A61122CQ36366800-93CE07EE-C14C-46D4-8C95-B59B6F3322D5Q36580051-B2C8D1EF-61C1-4B30-9930-81B74088FC01Q36661099-25AE191B-EF48-4D80-81C6-6C84A54A6B68Q37349868-331D8122-9F33-4037-8E6F-2D1DA9F46747Q37721268-98BC2970-0B97-406C-9BBA-904B8390A8F9Q38636378-D4C65ACB-F65F-4D80-B957-3ECFDF7F527FQ38647035-4177909D-54CD-43EE-9E91-8B170AB489BDQ38718345-AB4DBB42-A0C9-4442-91D3-097F87AFA7D9Q38797653-67147A7A-C877-42F5-877E-239C759EF553Q38815462-48CAB73A-F019-4056-9D04-092F1A3186DCQ38837641-400FAC8E-5287-412E-84D0-F9C8C02C9C11Q38955513-D4A6A844-6895-43A5-BF83-C57360322C21Q38962476-0824FDA1-553A-49A2-A532-4B0AE85E63ACQ38993187-622107A6-37E8-482D-922E-5804849D558EQ41707195-5B497B3E-FF3C-4B2F-9626-96BE2C20CA93Q42694570-77C84B52-7664-4302-954F-0DB928E2774AQ47658896-DAE43B03-A8B5-4E6C-85C0-74D84E4F995FQ47677895-A505F017-C273-4123-94F9-2EB964B6F333Q48022573-42838576-90C7-47FE-8682-76D9C484BBA3Q52690197-9AE495A5-B94E-4069-8716-024513C687BAQ55024304-3973D433-0A05-4FD7-9567-0DA888920E5AQ58575852-DF7262A3-C67C-4A69-9CCA-1275BF0DB246Q58580517-A9B3FEB9-6648-4A5F-9A07-12C4B885C044
P2860
Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Adjunctive raloxifene treatmen ...... and women with schizophrenia.
@ast
Adjunctive raloxifene treatmen ...... and women with schizophrenia.
@en
Adjunctive raloxifene treatmen ...... and women with schizophrenia.
@nl
type
label
Adjunctive raloxifene treatmen ...... and women with schizophrenia.
@ast
Adjunctive raloxifene treatmen ...... and women with schizophrenia.
@en
Adjunctive raloxifene treatmen ...... and women with schizophrenia.
@nl
prefLabel
Adjunctive raloxifene treatmen ...... and women with schizophrenia.
@ast
Adjunctive raloxifene treatmen ...... and women with schizophrenia.
@en
Adjunctive raloxifene treatmen ...... and women with schizophrenia.
@nl
P2093
P2860
P50
P356
P1433
P1476
Adjunctive raloxifene treatmen ...... n and women with schizophrenia
@en
P2093
C Galletly
C S Weickert
D Weinberg
J Kulkarni
M O'Donnell
P2860
P2888
P304
P356
10.1038/MP.2015.11
P407
P577
2015-05-18T00:00:00Z